Abstract: A pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma comprising the extract of Decaspermum fruticosum as an active ingredient. The extract of Decaspermum fruticosum of the present invention inhibited the increase of eosinophils in bronchoalveolar lavage fluid of the ovalbumin induced asthma animal model, had the activity of inhibiting the secretions of immunoglobulin and chemokine (Eotaxin) in bronchoalveolar lavage fluid and blood, and inhibited the secretions of NO and TNF-? in macrophages. Therefore, the extract of Decaspermum fruticosum of the present invention can be effectively used as an active ingredient of a pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma, and of a health functional food for the prevention and improvement of inflammatory disease or asthma.

Abstract: Disclosed is a pharmaceutical composition for the prophylaxis and therapy of inflammatory diseases, allergic diseases, or asthma, comprising a velvet apple (Diospyros blancoi A. DC.) extract as an active ingredient. Having the inhibitory activity against the nuclear translocation of NF-?B, whose level is rapidly elevated in response to inflammatory stimuli, the velvet apple extract can suppress the production of NO and PGE2, the expression of iNOS and COX-2, and the release of IL-1? and TNF-?, and can significantly down regulate Th2-mediated IL-4 and IL-13 production. In addition, the extract was found to inhibit the activation of eosinophils in bronchoalveolar lavage fluid, and to suppress the secretion of immunoglobulins and chemokines in bronchoalveolar lavage fluid and blood, as measured by in vivo tests on an ovalbumin-induced asthma mouse model. Therefore, the extract can be used in the method for preventing or treating various inflammatory disorders, allergic diseases, or asthma.

Abstract: Disclosed are a positive active material composition for an electrochemical device, a positive electrode, and an electrochemical device including the same. The positive active material composition includes: a carbon-based additive including a hydroxyl group (—OH) and an enol group (—C?C—OH) on the surface, having a peak area ratio (OH/C?COH) of a hydroxyl group peak area and an enol group peak area of an infrared spectroscopy (FT-IR) spectrum ranging from about 0.5 to about 10, having a specific surface area of about 50 m2/g to about 3000 m2/g, and having an oxygen-containing heterogeneous element in a content of less than about 15 wt %; a positive active material; a conductive material; and a binder.

Abstract: The present invention relates to a pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma comprising the extract of Decaspermum fruticosum as an active ingredient. The extract of Decaspermum fruticosum of the present invention inhibited the increase of eosinophils in bronchoalveolar lavage fluid of the ovalbumin-induced asthma animal model, had the activity of inhibiting the secretions of immunoglobulin and chemokine (Eotaxin) in bronchoalveolar lavage fluid and blood, and inhibited the secretions of NO and TNF-? in macrophages. Therefore, the extract of Decaspermum fruticosum of the present invention can be effectively used as an active ingredient of a pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma, and of a health functional food for the prevention and improvement of inflammatory disease or asthma.

Abstract: Disclosed is a pharmaceutical composition for the prophylaxis and therapy of inflammatory diseases, allergic diseases, or asthma, comprising a velvet apple (Diospyros blancoi A. DC.) extract as an active ingredient. Having the inhibitory activity against the nuclear translocation of NF-?B, whose level is rapidly elevated in response to inflammatory stimuli, the velvet apple extract can suppress the production of NO and PGE2, the expression of iNOS and COX-2, and the release of IL-1? and TNF-?, and can significantly down regulate Th2-mediated IL-4 and IL-13 production. In addition, the extract was found to inhibit the activation of eosinophils in bronchoalveolar lavage fluid, and to suppress the secretion of immunoglobulins and chemokines in bronchoalveolar lavage fluid and blood, as measured by in vivo tests on an ovalbumin-induced asthma mouse model. Therefore, the extract can be used in the method for preventing or treating various inflammatory disorders, allergic diseases, or asthma.

Abstract: A battery module for a rechargeable battery. The battery module has low contact resistance and includes: a plurality of electrode assemblies incorporating a positive electrode, a negative electrode and a separator disposed between the positive electrode and the negative electrode; a housing installed with the electrode assembly; and at least one conductive barrier inserted in the housing thereby dividing the space inside the housing, and electrically connecting the plurality of electrode assemblies.

Abstract: Disclosed are a negative active material for a rechargeable lithium battery and a rechargeable lithium battery including the same. The active material includes a silicon-containing compound represented by the following Chemical Formula 1. SiCx ??[Chemical Formula 1] wherein, 0.05?x?1.5; wherein the compound is substantially amorphous.

Abstract: Disclosed are a positive active material composition for an electrochemical device, a positive electrode, and an electrochemical device including the same. The positive active material composition includes: a carbon-based additive including a hydroxyl group (—OH) and an enol group (—C?C—OH) on the surface, having a peak area ratio (OH/C?COH) of a hydroxyl group peak area and an enol group peak area of an infrared spectroscopy (FT-IR) spectrum ranging from about 0.5 to about 10, having a specific surface area of about 50 m2/g to about 3000 m2/g, and having an oxygen-containing heterogeneous element in a content of less than about 15 wt %; a positive active material; a conductive material; and a binder.

Abstract: A rechargeable battery that can have high energy density and high power density. The rechargeable battery includes: bipolar electrodes including a current collector, a sealing layer that is formed at the edge of the current collector, a first electrode active material layer that is inserted into a space in that is formed within the sealing layer, and a second electrode active material layer that is formed at the opposite side of the first electrode active material layer; and a separator that is disposed between the bipolar electrodes, wherein the sealing layer is bonded with the sealing layer of neighboring bipolar electrodes.

Abstract: A battery module for a rechargeable battery. The battery module has low contact resistance and includes: a plurality of electrode assemblies incorporating a positive electrode, a negative electrode and a separator disposed between the positive electrode and the negative electrode; a housing installed with the electrode assembly; and at least one conductive barrier inserted in the housing thereby dividing the space inside the housing, and electrically connecting the plurality of electrode assemblies.

Abstract: The present disclosure relates to a fuel cell stack capable of making fuel flow within the stack uniform. One embodiment of the present disclosure is configured to provide a fuel cell stack comprising: a stack comprising a plurality of fuel cells disposed in a stack body, a fuel manifold in the stack body fluidly connected to the plurality of fuel cells, an oxidant manifold in the stack body fluidly connected to the plurality of fuel cells, and a baffle disposed in the fuel manifold comprising a longitudinal recess wherein a cross-section of the recess reduces in one direction.

Abstract: A fuel cell system is provided including a fuel cell stack and a starting controller. The fuel cell stack has output terminals for applying an output voltage. The starting controller is configured to control the output voltage applied across the output terminals of the fuel cell stack during a starting period to be a starting voltage lower than a rated voltage.

Abstract: An air-breathing-type polymer electrolyte membrane fuel cell and an operating method thereof capable of being stably started and operated by controlling an output current and temperature of a fuel cell stack in a predetermined range is controlled in a predetermined range so that the initial driving time of the system can be shortened through the high current operation in the low output state. The operating method of the air-breathing-type polymer electrolyte membrane fuel cell includes the steps of detecting an output current of a fuel cell stack; comparing a maximum reference value and a minimum reference value of the detected output current; and keeping the output current below the maximum reference value and above the minimum reference value.

Abstract: A membrane electrode assembly in a fuel cell system includes a cathode electrode that includes a support layer; a catalyst layer; and a first carbon layer and second carbon layer between the support layer and the catalyst layer, the first carbon layer having a relatively higher porosity and the second carbon layer having a relatively lower porosity. Therefore, the membrane electrode assembly maintains good ion conductivity in the polymer electrolyte membrane by suppressing the movement of water molecules from the polymer electrolyte membrane to the cathode electrode using a water pressure between two carbon layers having different porosity. Also, a flooding phenomenon in the cathode electrode is prevented, thereby maintaining the smooth movement of the oxidizing agent in the cathode.

Abstract: A fuel cell includes: a fuel cell body; and a fuel supplier supplying fuel to the fuel cell body, wherein the fuel cell body includes: a membrane electrode assembly including an ion exchange membrane, an anode catalyst layer positioned at one surface of the ion exchange membrane, an anode gas diffusion layer positioned at one surface of the anode catalyst layer, and a cathode catalyst layer positioned at other surface of the ion exchange membrane; and a fuel flow field positioned at the one surface of the anode gas diffusion layer and supplying the fuel to the anode catalyst layer through the anode diffusion layer.